(Chicago, IL) — Archer Daniels Midland Company (NYSE: ADM) announced on Wednesday a collaboration with Mayo Clinic in personalized nutrition. The company will work with Mayo’s Microbiome Program, led by Dr. Heidi Nelson, to investigate microbial solutions to improve health and wellness, initially focusing on the maintenance of healthy body weight.
“We are pleased to enter into this cutting-edge collaboration with Mayo Clinic to study the association of specific probiotics, prebiotics, and other nutrients with body weight,” said Vikram Luthar, ADM’s president, Bioactives. “Personalized nutrition is an important growth platform for ADM. Earlier this year, we acquired Biopolis, a leading player in health-promoting microbial technology. Now, by working with Mayo Clinic, we are further expanding our capabilities to develop personalized nutrition solutions to improve health and wellness, and bring these beneficial solutions directly to consumers.”
The goal of the collaboration is to develop a personalized nutrition model that predicts the effects of probiotics, prebiotics and other metabolites, as well as other nutrients in microbiome shifts, for improving individual health. In the initial phase, ADM and Mayo Clinic will work to design a computational method for testing probiotics, metabolites, and other intervention strategies that promote the growth of gut microbes linked to healthy body weight. Additional projects are planned to leverage both organizations’ strengths. Mayo Clinic will provide data analysis, modeling and gut microbiome expertise. ADM will bring expertise in food ingredients, strain development and genomics, as well as commercialization capabilities.